"Defending the inventor, armed with the patent shield,

under the banner of inventions promoting progress..."

versione italiana deutsch version

MODIANO & PARTNERS

Modiano & Partners is one of the leading European firms specializing exclusively in intellectual property law, with a staff of over 250 persons and main offices in Munich (Germany), Milan (Italy), and Lugano (Switzerland).

Our firm offers highly specialist assistance on all facets of intellectual property law, with over 50 patent attorneys (including qualified mechanical, electrical, software and chemical engineers, and qualified geneticists, chemists and biologists), over 50 trademark attorneys and 10 lawyers and barristers, and in particular in the following fields:

  • Patents
  • Trademarks
  • Litigation
  • Licensing
  • Designs
  • Internet
  • Unfair competition

NEWS

April 22, 2015
欧专局简化专利申请文件

众所周知, 欧洲专利局因其检索能力著称, 也对其特有的检索系统引以为豪. 但是, 最近欧洲专利局决定开始利用其他专利局的检索报告, 并将其作为特定发明相关技术领域的现有技术和/或信息的补充资料. 因而, 若某个欧洲专利申请要求享有在先申请的优先权, 该申请人应同时提交在先申请的受理局所做出的检索报告的副本. 此类检索结果应与欧洲专利申请一并提交; 若该欧洲申请是基于P C T的申请, 则应在其进入欧洲阶段时提交. 如果此时尚未获得检索报告, 申请人应在收到检索结果后尽快提交. 为使该程序更加高效, 欧专局做出最新决定: 在某些特定情形下, 申请人实际上并不需要提交优先权申请检索结果的副本. […]



January 21, 2015
欧洲专利局就“重复专利申请”作出决定

在2014 年出台的两个重要决定中, 欧洲专利局的上诉委员会对“ 重复专利申请” 问题作出了 裁定. 在这两个案例中, 申请人都提交了欧洲专利申请以及基于原申请的分案申请.原申请中“瑞士型权利要求”获得授权, 其权利要求具体为“使用活性成分X制备用于治疗疾病Y的药物”.在2007年欧洲专利公约2000版(E P C2000)生效前, 此类将已知活性成分用作新用途的权利要求是可以使用的.但是, 其分案申请却因使用“以方法界定产品”的权利要求引发上诉.分案申请的权利要求为“用于治疗疾病Y的活性成分X”, E P C2000改革后允许使用此类权利要求. 考虑到母申请和分案申请中的活性成分X和疾病Y均相同, 欧专局上诉委员会的两个决定所针对的问题在于上述情况中是否存在“重复申请”情形. 在这两个案例中, 欧专局审查部门均驳回了分案申请, […]




» See All News

banner_nl_eng

banner_video


  DOCUMENTS & FORMS


My Modiano »
Please note that a valid certificate, provided by Modiano & Partners, is required to access this reserved area.

To use reCAPTCHA you must get an API key from https://www.google.com/recaptcha/admin/create